Hormone Therapy and Compounding: Why Personalized Dosing Matters
Hormones regulate nearly every system in your body. When they're off, standard one-size doses rarely get them right. Here's why precision matters.
If you have ever been prescribed a hormone medication and felt like the dose was not quite right - symptoms lingering, side effects emerging, or the whole thing just feeling off - there is a reason for that. Commercial hormone products come in a handful of fixed doses. Your body does not operate in those increments. The dose that works for one person may be too much or too little for someone else, and the delivery method matters just as much as the dose itself.
At Griffin Concierge Medical, hormone optimization is one of the most personalized things we do. We use comprehensive lab work to understand exactly where your levels are, prescribe bioidentical hormones at precise doses through our partnership with Restore Pharmacy, and monitor your response through follow-up labs and regular check-ins. Compounding allows us to match the dose and delivery method to you - rather than rounding to the nearest commercially available option and hoping for the best.
This article explains why personalized dosing matters, how compounding makes it possible, and what the evidence says about the hormones we most commonly optimize for our members.
Why Standard Doses Fall Short
Commercial hormone products are manufactured in a limited number of fixed doses. Estradiol patches, for example, come in 0.025, 0.05, 0.075, and 0.1 mg strengths. Testosterone cypionate is available in 100mg/mL and 200mg/mL concentrations. Progesterone capsules come in 100mg and 200mg.
The human body doesn't operate in these neat increments. A woman who needs 0.0375 mg of transdermal estradiol doesn't have a commercially available option at that exact dose. A man whose optimal testosterone dose is 80mg twice weekly can't draw that precisely from a standard 200mg/mL vial without a compounding pharmacy preparing the right concentration.
These dosing gaps matter more than they might seem. Hormones operate within narrow therapeutic windows. Too little, and symptoms persist. Too much, and side effects emerge. The difference between an effective and a problematic dose can be measured in milligrams or fractions of milligrams. When you are working within those margins, the ability to prescribe an exact dose - not the closest available option - directly affects how you feel.
An estimated 80% of hormone therapy patients require dose adjustments within the first year. Compounding makes precise titration possible without being limited to fixed commercial increments.
"Hormones are a precision game. The same way we would never round a cardiac medication to the nearest available dose, we take the same approach with hormone therapy. When you can prescribe exactly what a patient needs, the results are consistently better."
Dr. Radley Griffin, Griffin Concierge MedicalThe Hormones We Optimize - and Why Delivery Matters
Estrogen (Women)
Estrogen decline during perimenopause and menopause produces symptoms that range from disruptive (hot flashes, sleep disruption, mood changes, vaginal dryness) to clinically significant (accelerated bone loss, cardiovascular risk changes, cognitive decline). Hormone therapy can address both.
The critical nuance is how estrogen is delivered. Oral estrogen undergoes first-pass metabolism in the liver, increasing production of SHBG, clotting factors (raising thrombotic risk), and inflammatory markers. Transdermal estradiol - delivered as a patch, gel, or compounded cream - bypasses the liver entirely, avoiding these effects while still providing the systemic benefits.
Research since the Women's Health Initiative has clarified that transdermal bioidentical estradiol combined with micronized progesterone carries a substantially more favorable risk profile than the oral conjugated equine estrogen and synthetic progestin used in the original WHI study. The timing of initiation also matters: therapy started within 10 years of menopause or before age 60 carries the greatest benefit-to-risk ratio.
Compounding gives us precise control over estradiol concentration in transdermal preparations, allowing fine-tuned titration based on serum levels and symptom response.
Progesterone (Women)
Progesterone is essential for any woman with an intact uterus who is taking estrogen therapy - it protects against endometrial hyperplasia. But progesterone has benefits beyond endometrial protection: it supports sleep quality (through its GABA-agonist metabolite, allopregnanolone), has anxiolytic properties, and supports healthy breast tissue.
Micronized progesterone (the bioidentical form) is preferred over synthetic progestins, which have different metabolic effects and risk profiles. Commercial micronized progesterone (Prometrium) is available in 100mg and 200mg capsules. Compounding allows us to adjust to any dose - and to provide it in alternative delivery forms (vaginal suppositories, transdermal creams, sublingual troches) that may be preferable for specific clinical situations.
Testosterone (Men and Women)
Testosterone optimization in men is covered in depth in our testosterone article. In the context of compounding, the key advantages are precise dosing of injectable testosterone cypionate at concentrations that allow accurate twice-weekly subcutaneous injection, and transdermal preparations at specific strengths.
For women, low-dose testosterone can address low libido, fatigue, cognitive fog, and declining muscle mass that often accompanies menopause. Women require doses roughly 10-20 times lower than men - typically 1-5mg daily via compounded transdermal cream. These ultra-low concentrations are not available in any commercial product. Compounding is essentially the only option for female testosterone therapy at appropriate doses.
For a deeper look at testosterone optimization for men, see our comprehensive testosterone article.
Thyroid (T3/T4 Combinations)
Standard thyroid replacement therapy uses levothyroxine (synthetic T4), relying on the body to convert it to the active hormone T3. For many patients, this works well. But a subset of patients - particularly those with impaired T4-to-T3 conversion (common with inflammation, cortisol dysregulation, selenium deficiency, or genetic variants in the DIO2 deiodinase enzyme) - remain symptomatic on T4 alone.
Compounded T3/T4 combination preparations allow us to provide both hormones in a specific ratio tailored to the patient's conversion capacity and lab values. Commercial combination products (like Armour Thyroid, a porcine-derived preparation) provide a fixed T4:T3 ratio that may not match what a specific patient needs. Compounding lets us adjust each component independently.
DHEA
DHEA is an adrenal-produced precursor hormone that declines with age and under chronic stress. It serves as a building block for both testosterone and estrogen and has independent effects on immune function, bone density, mood, and cognitive performance. As we discussed in our cortisol and burnout article, DHEA-S levels are often depleted in patients with HPA axis dysregulation.
While DHEA is available over the counter as a supplement, pharmaceutical-grade compounded DHEA ensures consistent potency and purity - important for a hormone where dosing precision matters and supplement-grade products have variable quality.
The Lab-Guided Approach
At Griffin Concierge Medical, every hormone prescription is guided by comprehensive lab work - before initiation, 6-8 weeks after starting or adjusting, and at regular intervals during treatment. The specific panels depend on the hormones being prescribed:
| Hormone | Key Labs Monitored | Monitoring Frequency |
|---|---|---|
| Estradiol | Serum estradiol, SHBG, FSH, metabolic panel, lipids | 6-8 weeks post-initiation; then every 6 months |
| Progesterone | Serum progesterone (timed), endometrial assessment if indicated | 6-8 weeks post-initiation; then every 6 months |
| Testosterone (Men) | Total T, free T, SHBG, estradiol, hematocrit, PSA, lipids | 6-8 weeks; then every 3-4 months year one; every 6 months stable |
| Testosterone (Women) | Total T, free T, SHBG, estradiol, DHEA-S | 6-8 weeks post-initiation; then every 6 months |
| Thyroid (T3/T4) | TSH, free T3, free T4, reverse T3, thyroid antibodies | 6-8 weeks; then every 3-6 months |
| DHEA | DHEA-S, testosterone, estradiol (to monitor downstream conversion) | 6-8 weeks; then every 6 months |
This monitoring cadence is non-negotiable. Hormone therapy without regular lab surveillance is blind prescribing. The labs tell us whether the dose is right, whether downstream hormones are balanced, and whether safety markers (hematocrit, lipids, PSA) remain within acceptable ranges.
Three Hormones, One Member, Zero Standard Doses
A female member in her early 50s came to Griffin during the first year of menopause with severe hot flashes, insomnia, brain fog, low libido, and progressive fatigue. She had been on a standard 0.05mg estradiol patch and 100mg oral progesterone for three months with minimal improvement.
Her labs with us confirmed subtherapeutic estradiol levels despite the patch, low free testosterone, and DHEA-S in the bottom quartile. Her progesterone levels were adequate, but she reported significant morning drowsiness from the sedating effect of the oral capsule.
Through Restore Pharmacy, we compounded a transdermal estradiol cream at a precise concentration titrated to her body surface area, a low-dose testosterone cream at 2mg daily, and switched her progesterone to a vaginal suppository at 150mg - a dose unavailable commercially - eliminating the morning sedation while maintaining endometrial protection.
At her eight-week follow-up, serum estradiol was in our target range, free testosterone had normalized, and her symptoms had resolved substantially. None of the three hormone preparations she is now using exist as a commercially available product at the doses she needs. That is what personalized compounding makes possible.
Wondering if your current hormone therapy could be optimized? Bring it up at your next Griffin visit, or contact your patient care coordinator to schedule a hormone review. We can evaluate your current regimen, run the labs, and determine whether a compounded formulation would serve you better.
Why the Pharmacy Matters as Much as the Prescription
Compounding quality varies between pharmacies, and with hormones, quality directly affects outcomes. A testosterone cream that's 15% less potent than specified produces sub-therapeutic levels. A progesterone suppository that doesn't maintain potency through its shelf life fails its protective function.
Our partnership with Restore Pharmacy was chosen specifically because of their quality control protocols: potency verification of each batch, pharmaceutical-grade ingredient sourcing, and direct pharmacist-to-physician communication when clinical questions arise. When we adjust a dose by 10mg, we need to know the pharmacy delivered exactly that adjustment.
Bioidentical vs. Synthetic: What the Evidence Actually Shows
The term "bioidentical" generates strong reactions in both directions - advocates treat it as inherently superior, while skeptics dismiss it as marketing. The reality is more straightforward:
- Bioidentical hormones are molecularly identical to human hormones. Bioidentical estradiol (17β-estradiol) is the same molecule your ovaries produce. Bioidentical testosterone is the same molecule your testes produce. This isn't debatable - it's chemistry.
- Several FDA-approved bioidentical products exist. Estradiol patches, micronized progesterone (Prometrium), and testosterone preparations are all bioidentical and commercially available. "Bioidentical" doesn't automatically mean "compounded."
- Synthetic hormones have different molecular structures. Medroxyprogesterone acetate (Provera) is not progesterone - it's a progestin with a different side-effect profile. Conjugated equine estrogens (Premarin) contain estrogen molecules not produced by the human body. These molecular differences have clinical implications.
- The WHI's results are often misapplied. The Women's Health Initiative studied Premarin and Provera in older women (average age 63). Extrapolating those results to bioidentical estradiol and micronized progesterone in perimenopausal women is not scientifically appropriate.
- Compounding adds value when commercial bioidentical products don't fit. If a commercial bioidentical product at a standard dose achieves the clinical goal, compounding isn't necessary. Compounding becomes valuable when the patient needs a dose, combination, or delivery method that commercial products don't offer.
If you are a Griffin member and want to explore whether your hormone therapy could be better tailored to your body, bring it up at your next visit or contact your patient care coordinator. Whether you are considering hormone therapy for the first time or wondering whether your current regimen could be improved, your Griffin physician can walk you through the options and build a plan based on your labs, your symptoms, and your goals.
Ready to Talk About Hormone Optimization?
Contact your Griffin physician or patient care coordinator to schedule a hormone evaluation. We start with comprehensive lab work, identify what your body actually needs, and build a personalized protocol through our compounding pharmacy partnership.
If you are not yet a member, contact us to learn more about how Griffin approaches personalized medicine.
Key Takeaways
- Hormones are a precision game. Small dose differences produce measurable clinical effects. Fixed commercial doses don't fit every member.
- Delivery method affects safety and efficacy. Transdermal estradiol has a better safety profile than oral. Injection frequency affects testosterone stability. Route matters.
- Compounding enables true personalization. When the right dose, combination, or delivery form doesn't exist commercially, a compounding pharmacy can create it.
- Lab monitoring is non-negotiable. Every hormone prescription requires baseline and follow-up labs to verify dose adequacy and safety.
- Bioidentical means molecularly identical. Not all bioidentical hormones need to be compounded, but when commercial options fall short, compounding fills the gap with the same molecules.
- The full hormonal picture matters. Estrogen, progesterone, testosterone, thyroid, DHEA, and cortisol are interconnected. Optimizing one in isolation often isn't sufficient.
Frequently Asked Questions
Bioidentical hormones are molecules that are structurally identical to the hormones your body naturally produces. Bioidentical estradiol, progesterone, and testosterone have the same molecular structure as human-produced versions. This is distinct from synthetic hormones like medroxyprogesterone acetate (Provera) or conjugated equine estrogens (Premarin), which have different structures. Several FDA-approved bioidentical products exist commercially. Compounding provides additional options for dose customization and delivery methods not available commercially.
Commercial hormone products come in fixed, manufacturer-determined doses and delivery forms. Compounded hormone preparations are custom-made by a compounding pharmacy to a physician's exact specifications - allowing precise dose adjustments, allergen-free formulations, and delivery methods (creams, troches, pellets, suppositories) that may not be available commercially. Compounding is most valuable when commercial options don't provide the right dose, form, or combination for an individual member's needs.
The safety profile depends on the type of hormones used, the delivery method, the timing of initiation, and individual risk factors. Research since the Women's Health Initiative has clarified that bioidentical estradiol (particularly transdermal) combined with micronized progesterone carries a more favorable risk profile than the synthetic hormones used in the original WHI study. For women within 10 years of menopause or under age 60, the benefits of hormone therapy generally outweigh the risks when properly monitored.
Dosing at Griffin Concierge Medical is guided by comprehensive lab work, clinical symptoms, and ongoing monitoring. We start at conservative doses, recheck levels at 6-8 weeks, and titrate based on both objective lab values and subjective symptom response. The goal is the minimum effective dose that resolves symptoms and optimizes markers. Compounding allows us to make precise dose adjustments that commercial products don't permit.
Different delivery methods produce different pharmacokinetic profiles. Oral estrogen undergoes first-pass liver metabolism, which increases SHBG, clotting factors, and inflammatory markers. Transdermal estrogen bypasses the liver, avoiding these effects and carrying a lower thrombotic risk. Testosterone administered transdermally produces steadier levels than less frequent injections. The delivery method directly affects efficacy, safety, and side effect profiles.
Often, yes. Testosterone doesn't exist in isolation. DHEA may be depleted, particularly in men under chronic stress. Thyroid function affects how testosterone is metabolized and utilized. Estradiol management is critical on testosterone therapy. Cortisol levels directly impact testosterone production. A comprehensive approach evaluates and optimizes the entire hormonal ecosystem, not just a single number.
